Literature DB >> 6110596

Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon.

S J Bhathena, J Louie, G P Schechter, R S Redman, L Wahl, L Recant.   

Abstract

Mononuclear leukocytes (MNL) were isolated from human blood by Ficoll-Hypaque. These cells were further separated into lymphocyte (L) and monocyte (M) enriched fractions. L contained 99% lymphocytes and M contained 74% monocytes, a threefold enrichment over MNL. Specific binding to somatostatin, glucagon, and insulin was measured in the three fractions. Binding of all three hormones in the M fraction was increased by a factor of 3 compared with MNL and was linear with cell number. Binding of glucagon and insulin to the L fraction was very low while, in contrast, somatostatin binding was substantial and linear with lymphocyte number. Autoradiography confirmed the binding of glucagon to monocytes and of somatostatin to both monocytes and lymphocytes. Somatostatin is the first of the peptide hormones shown to bind to both types of circulating mononuclear cells, perhaps complicating quantification of somatostatin binding in disease states in which differential alteration of binding of lymphocytes or monocytes might occur.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6110596     DOI: 10.2337/diab.30.2.127

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  25 in total

1.  Effect of substance P and somatostatin on migration of polymorphonuclear (PMN) cells in vitro.

Authors:  G Partsch; M Matucci-Cerinic
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

2.  Measles virus modulates human T-cell somatostatin receptors and their coupling to adenylyl cyclase.

Authors:  S Krantic; A Enjalbert; C Rabourdin-Combe
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 3.  Growth hormone. A paracrine growth factor?

Authors:  S Harvey; K L Hull
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

4.  Somatostatin receptors on human lymphocytes and leukaemia cells.

Authors:  K Hiruma; T Koike; H Nakamura; T Sumida; T Maeda; H Tomioka; S Yoshida; T Fujita
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

5.  Increased uptake of indium-111 pentetreotide up to 10 years after external thoracic irradiation: report of two cases.

Authors:  M Stoffel; F Jamar; J Donckier; P Hainaut; P Decoster; C Beckers; S Pauwels
Journal:  Eur J Nucl Med       Date:  1996-06

Review 6.  Somatostatin receptor expression in non-classical locations - clinical relevance?

Authors:  Eldrin Bhanat; Christian A Koch; Rinkuben Parmar; Vishnu Garla; Vani Vijayakumar
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

Review 7.  Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors:  E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal:  Eur J Nucl Med       Date:  1993-08

8.  Differential effect of the immunomodulatory hormone somatostatin on replication of human immunodeficiency virus type 1 in CD4+ and CD8+ T lymphocytes.

Authors:  L Mercure; D Phaneuf; M A Wainberg
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

9.  Identification of glucagon receptors in human adipocytes from a liposarcoma.

Authors:  M C Carranza; M A Simón; A Torres; B Romero; C Calle
Journal:  J Endocrinol Invest       Date:  1993-06       Impact factor: 4.256

10.  Inhibition of recombinant human growth hormone-induced and prolactin-induced activation of neutrophils by octreotide.

Authors:  C J Wiedermann; N Reinisch; M Niedermühlbichler; H Braunsteiner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.